Monoklonale Antikörper in Diagnostik und Verlaufskontrolle des Ovarialkarzinoms. CA 125 als Tumormarker

Autor:	H. Caffier, R. Kreienberg, P. Schmidt-Rhode, G. Sturm, H. Würz, G. Crombach, F. J. Hoffmann, H. Kaesemann, V. Möbus
Rok vydání:	1986
Předmět:	Immunoradiometric assay medicine.drug_class business.industry CA 15-3 General Medicine medicine.disease Monoclonal antibody Molecular medicine Molecular biology Cancer antigen Antigen Drug Discovery Clinical validity medicine Molecular Medicine Ovarian cancer business Genetics (clinical)
Zdroj:	Klinische Wochenschrift. 64:781-785
ISSN:	1432-1440 0023-2173
DOI:	10.1007/bf01732187
Popis:	The clinical validity of using the cancer antigen (CA) 125 — a surface antigen on malignant epithelial ovarian tumors — for diagnosis and follow-up of ovarian cancer was investigated in a cooperative study. Using a monoclonal antibody (OC 125) to detect CA 125, the sera of 850 patients were analyzed by immunoradiometric assay (IRMA-Kit Centocor).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::411b9d48ebeb716e0313dfe1659a184a https://doi.org/10.1007/bf01732187 Zobrazit plný text záznamu Full text from SpringerLink